Jazz Pharmaceuticals (JAZZ) EBT Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) recorded quarterly EBT Margin of 27.99% in Q1 2026, up 60.85% quarter-over-quarter from 17.4% in Q4 2025, and up 4022.0% on a YoY basis from 0.68% in Q1 2025.
Jazz Pharmaceuticals (JAZZ) EBT Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 27.99% for Q1 2026.
- In Q1 2026, EBT Margin rose 4022.0% year-over-year to 27.99%; the TTM figure through Mar 2026 stood at 4.93% (down 1384.0% YoY), while the FY2025 annual figure was 14.71%, down 2627.0% from the prior year.
- EBT Margin was 27.99% for Q1 2026 at Jazz Pharmaceuticals, up from 17.4% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 27.99% in Q1 2026 to a low of 70.34% in Q2 2025.
- Historically, EBT Margin has averaged 0.05% across 5 years, with a median of 6.08% in 2023.
- The sharpest annual moves came in 2023 and 2025: EBT Margin jumped 4105 bps in 2023, then sank 8381 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 34.97% in 2022, then surged by 117 bps to 6.08% in 2023, then jumped by 101 bps to 12.24% in 2024, then soared by 42 bps to 17.4% in 2025, then soared by 61 bps to 27.99% in 2026.
- The last three EBT Margin figures came in at 27.99% (Q1 2026), 17.4% (Q4 2025), and 0.8% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | 27.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.99% |
| Dec 31, 2025 | 17.40% |
| Sep 30, 2025 | 0.80% |
| Jun 30, 2025 | -70.34% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 19.03% |
| Jun 30, 2024 | 13.47% |
| Mar 31, 2024 | -0.18% |
| Dec 31, 2023 | 6.08% |
| Sep 30, 2023 | 10.24% |
| Jun 30, 2023 | 8.54% |
| Mar 31, 2023 | 6.17% |
| Dec 31, 2022 | -34.97% |
| Sep 30, 2022 | -6.39% |
| Jun 30, 2022 | 2.25% |
| Mar 31, 2022 | 0.78% |
| Dec 31, 2021 | -5.00% |
| Sep 30, 2021 | -8.07% |
| Jun 30, 2021 | -18.10% |